Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
BMC Public Health|July 13, 2011
Impact of targeted interventions on heterosexual transmission of HIV in IndiaRajesh Kumar, Sanjay M Mehendale, Samiran Panda, et al.The New England Journal of Medicine|November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couplesRochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.Plos One|May 9, 2017
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052Philip J Palumbo, Ethan A Wilson, Estelle Piwowar-Manning, et al.Scientific Reports|July 10, 2025
Progress and challenges towards eliminating vertical transmission of HIV in IndiaPradeep Kumar, Chinmoyee Das, Vishal Deo, et al.The Journal of Infectious Diseases|March 24, 2022
Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 StudiesFeixue Wei, Ningshao Xia, Rebeca Ocampo, et al.HIV Clinical Trials|April 8, 2017
Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H Eshleman, Ethan A Wilson, Xinyi C Zhang, et al.PLOS Global Public Health|May 7, 2025
Programmatic mapping and population size estimation of key population in India: Method and findingsPradeep Kumar, Chinmoyee Das, Bhawani Singh Khushwaha, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2016
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 TrialJessica M Fogel, Sarah E Hudelson, San-San Ou, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 3, 2018
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052Philip J Palumbo, Jessica M Fogel, Sarah E Hudelson, et al.The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.Pageof 19